The exploratory randomized controlled trial by high-dose Asacol treatment to patients with ulcerative colitis aiming to maintain remission.
Phase of Trial: Phase II
Latest Information Update: 17 May 2016
Price : $35 *
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms Asacol4-8maintenance
- 28 Mar 2015 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan record.
- 12 Jun 2013 New trial record